Foltyn, M., Luger, A., Lorenz, N. I., Sauer, B., Mittelbronn, M., Harter, P. N., . . . Ronellenfitsch, M. W. (2019). The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma. Br J Cancer.
Chicago Style aipamenaFoltyn, Martha, Anna-Luisa Luger, Nadja I. Lorenz, Benedikt Sauer, Michel Mittelbronn, Patrick N. Harter, Joachim P. Steinbach, and Michael W. Ronellenfitsch. "The Physiological MTOR Complex 1 Inhibitor DDIT4 Mediates Therapy Resistance in Glioblastoma." Br J Cancer 2019.
MLA aipamenaFoltyn, Martha, et al. "The Physiological MTOR Complex 1 Inhibitor DDIT4 Mediates Therapy Resistance in Glioblastoma." Br J Cancer 2019.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.